JENNIFER MODESTO: Open Payments
NPI 1750483244 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,568 in 133 payments from 15 companies in 2025. Trend: 2023 $748 · 2024 $993 · 2025 $2,568
Food & beverage: $2,404Education: $164
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $406 |
| GENZYME CORPORATION | 13 | $400 |
| E.R. Squibb & Sons, L.L.C. | 13 | $283 |
| ABBVIE INC. | 19 | $278 |
| Regeneron Healthcare Solutions, Inc. | 10 | $243 |
| PFIZER INC. | 10 | $171 |
| Galderma Laboratories, L.P. | 17 | $165 |
| Novartis Pharmaceuticals Corporation | 10 | $138 |
| Amgen Inc. | 5 | $108 |
| Lilly USA, LLC | 5 | $98 |
Products named: DUPIXENT, TREMFYA, Sotyktu, CIBINQO, SKYRIZI, NEMLUVIO, RINVOQ, COSENTYX.
Industry payments across FL — which companies pay providers there.
